Learn more about the Clinton Health Access Initiative's work in Global Health

Global Health

Global Health

Working closely with governments and other partners, we aim to strengthen in-country health systems and improve global markets for medicines and diagnostics – ensuring lifesaving treatments and care can reach the people who need them the most. Our goal is to transform these systems and ensure they develop into self-sustaining methods of providing low-cost, high-quality care.

Support the Clinton Foundation's work around the world.
Donate Today

More About Our Work in Global Health

Although treatments exist for infectious diseases such as HIV/AIDS, malaria, and tuberculosis, the developing world has had limited access to these treatments because of their high cost. A decade ago, only 200,000 people in developing countries were receiving treatment, with medicines that could cost over $10,000 per person annually. At its most basic level, this problem was one of economics: the market for these medicines was disorganized and operating at a low-volume, high-cost model. And developing health systems lacked the infrastructure to diagnose and treat patients properly.

By collaborating with manufacturers on the supply side and governments on the demand side – and transitioning the market to a high-volume, low-cost model – we have reduced the cost of key drugs and enabled millions of people to receive lifesaving treatment. We began our work in the Bahamas, and today, more than 70 countries are benefiting from treatments and diagnostics that we've helped to negotiate, and we've reduced the price of HIV/AIDS treatments up to 90 percent, and have provided more than one million HIV tests for infants in developing countries.

We've applied this model to address treatments for malaria, diarrhea, and tuberculosis, to improve access to diagnostics, and to scale up the delivery of lifesaving vaccines in countries such as India, Cambodia, Kenya, Nigeria, South Africa, and Uganda – where providers and consumers are often unaware of the recommended drugs or vaccines. We've used the same model to scale up the usage of these treatments and increase availability in both public and private facilities. By partnering with governments to address these challenges, we've helped to create evidence-based solutions that are tailor-made to each country's needs, and have helped developing countries save more than $3 billion since 2007. And through our human resources for health programs, we're working with governments to improve medical and health education to a generation of health professionals. We continue to work to economize and improve care in developing countries, with an ultimate goal of fundamentally changing the economics of global health and building health systems that are self-sustaining.